The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
Open accessAbstract
Parkinson's Disease (PD) is the second most common chronic neurodegenerative disease characterized by the progressive loss of dopamine neurons, leading to rigidity, slowness of movement, rest tremor, gait disturbances, and imbalance. Although there is effective symptomatic treatment for PD, there is no proven preventative or regenerative therapy. The etiology of this disorder remains unknown. Recent genetic studies have identified mutations in alpha-synuclein as a rare cause of autosomal dominant familial PD and mutations in parkin as a cause of autosomal recessive familial PD. The more common sporadic form of PD is thought to be due to oxidative stress and derangements in mitochondrial complex I activity. Understanding the mechanism by which familial linked mutations and oxidative stress cause PD has tremendous potential for unraveling the mechanisms of dopamine cell death in PD. In this article, we review recent advances in the understanding of the role of genetics and oxidative stress in the pathogenesis of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Wiklund, R. A., & Rosenbaum, S. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371606 · Cited by 2,149
A Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 1,994
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Parkinson, J. (2002) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.14.2.223 · Cited by 1,628
Conway, K. A., Lee, S.-J., Rochet, J.-C., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,541
Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,499
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,480
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Javitch, J. A., D'Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,263
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810153391607 · Cited by 1,201
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Agid, Y., Javoy‐Agid, F., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360305 · Cited by 1,161
Klivenyi, P., Andreassen, O. A., Ferrante, R. J., Dedeoglu, A., Mueller, G., Lancelot, E., Bogdanov, M., Andersen, J. K., Jiang, D., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00001.2000 · Cited by 1,111
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046
Self-citationThe Tyrosine Kinase Negative Regulator c-Cbl as a RING-Type, E2-Dependent Ubiquitin-Protein Ligase
Joazeiro, C. A. P., Wing, S. S., Huang, H.-K., Leverson, J. D., Hunter, T., & Liu, Y.-C. (1999) · Science · doi:10.1126/science.286.5438.309 · Cited by 1,034
Heikkila, R. E., Manzino, L., Cabbat, F. S., & Duvoisin, R. C. (1984) · Nature · doi:10.1038/311467a0 · Cited by 1,010
RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
Lorick, K. L., Jensen, J. P., Fang, S., Ong, A. M., Hatakeyama, S., & Weissman, A. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11364 · Cited by 981
The Neuron-Specific Protein PGP 9.5 Is a Ubiquitin Carboxyl-Terminal Hydrolase
Wilkinson, K. D., Lee, K., Deshpande, S., Duerksen-Hughes, P., Boss, J. M., & Pohl, J. (1989) · Science · doi:10.1126/science.2530630 · Cited by 871
Poly(ADP-ribose) polymerase: a molecular nick-sensor
de Murcia, G., & de Murcia, J. M. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90280-1 · Cited by 797
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23
Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I., Johnson, W. G., Ide, S. E., Di Iorio, G., Sanges, G., Stenroos, E. S., Pho, L. T., Schaffer, A. A., et al. (1996) · Science · doi:10.1126/science.274.5290.1197 · Cited by 788
Conway, K. A., Harper, J. D., & Lansbury, P. T. (2000) · Biochemistry · doi:10.1021/bi991447r · Cited by 786
Clayton, D. F., & George, J. M. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01213-7 · Cited by 779
Poly(ADP-Ribose) in the Cellular Response to DNA Damage
Berger, N. A. (1985) · Radiation Research · doi:10.2307/3576299 · Cited by 775
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Role of poly(ADP-ribose) synthetase in inflammation and ischaemia–reperfusion
Szabó, C., & Dawson, V. L. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01193-6 · Cited by 685
Self-citationPrzedborski, S., Jackson-Lewis, V, Yokoyama, R., Shibata, T., Dawson, V. L., & Dawson, T. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4565 · Cited by 624
Self-citationα-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins
Ostrerova, N., Petrucelli, L., Farrer, M., Mehta, N., Choi, P., Hardy, J., & Wolozin, B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05782.1999 · Cited by 564
Protein Nitration in Parkinsonʼs Disease
Good, P. F., Hsu, A., Werner, P., Perl, D. P., & Olanow, C. W. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00006 · Cited by 540
Prospects for new restorative and neuroprotective treatments in Parkinson's disease
Dunnett, S. B., & Björklund, A. (1999) · Nature · doi:10.1038/399a032 · Cited by 537
Abbas, N., Lucking, C. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.567 · Cited by 530
Binding of α-Synuclein to Brain Vesicles Is Abolished by Familial Parkinson's Disease Mutation
Jensen, P. H., Nielsen, M. S., Jakes, R., Dotti, C. G., & Goedert, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26292 · Cited by 511
Giasson, B. I., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7619 · Cited by 507
Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice
Saigoh, K., Wang, Y.-L., Suh, J.-G., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T., et al. (1999) · Nature Genetics · doi:10.1038/12647 · Cited by 502
Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions
Engelender, S., Kaminsky, Z., Guo, X., Sharp, A. H., Amaravi, R. K., Kleiderlein, J. J., Margolis, R. L., Troncoso, J. C., Lanahan, A. A., Worley, P. F., et al. (1999) · Nature Genetics · doi:10.1038/8820 · Cited by 489
Self-citationFrontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies
Spillantini, M. G., Bird, T. D., & Ghetti, B. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00162.x · Cited by 475
A susceptibility locus for Parkinson's disease maps to chromosome 2p13
Gasser, T., Müller-Myhsok, B., Wszolek, Z. K., Oehlmann, R., Calne, D. B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P., & Horstmann, R. D. (1998) · Nature Genetics · doi:10.1038/ng0398-262 · Cited by 458
Przedborski, S., Kostic, V, Jackson-Lewis, V, Naini, A., Simonetti, S., Fahn, S., Carlson, E., Epstein, C., & Cadet, J. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01658.1992 · Cited by 456
Jenco, J. M., Rawlingson, A., Daniels, B., & Morris, A. J. (1998) · Biochemistry · doi:10.1021/bi972776r · Cited by 431
Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro
Hashimoto, M., Hsu, L. J., Xia, Y., Takeda, A., Sisk, A., Sundsmo, M., & Masliah, E. (1999) · NeuroReport · doi:10.1097/00001756-199903170-00011 · Cited by 429
Galvin, J. E., Uryu, K., Lee, V. M.-Y., & Trojanowski, J. Q. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13450 · Cited by 422
Inhibition of neuronal nitric oxide synthase prevents MPTP–induced parkinsonism in baboons
Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R. T., & Beal, M. F. (1996) · Nature Medicine · doi:10.1038/nm0996-1017 · Cited by 422
Schulz, J. B., Matthews, R. T., Muqit, M. M. K., Browne, S. E., & Beal, M. F. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020936.x · Cited by 417
Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.
Takeda, A., Mallory, M. E., Sundsmo, M. P., Honer, W. G., Hansen, L. A., & Masliah, E. (1998) · Europe PMC (PubMed Central) · Cited by 403
Pathology and Biology of the Lewy Body
Pollanen, M. S., Dickson, D. W., & Bergeron, C. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199305000-00001 · Cited by 396
Irizarry, M. C., Growdon, W., Gomez-isla, T., Newell, K., George, J. M., Clayton, D. F., & Hyman, B. T. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199804000-00005 · Cited by 394
Mandir, A. S., Przedborski, S., Jackson-Lewis, V., Wang, Z.-Q., Simbulan-Rosenthal, C. M., Smulson, M. E., Hoffman, B. E., Guastella, D. B., Dawson, V. L., & Dawson, T. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5774 · Cited by 382
Self-citationJensen, P. H., Hager, H., Nielsen, M. S., Højrup, P., Gliemann, J., & Jakes, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25481 · Cited by 377
Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q
Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K., & Mizuno, Y. (1998) · Neurology · doi:10.1212/wnl.51.3.890 · Cited by 370
(1964) · The Lancet · doi:10.1016/s0140-6736(64)90527-6 · Cited by 370
Marek, K. L., Seibyl, J. P., Zoghbi, S. S., Zea-Ponce, Y., Baldwin, R. M., Fussell, B., Charney, D. S., van Dyck, C., Hoffer, P. B., & Innis, R. B. (1996) · Neurology · doi:10.1212/wnl.46.1.231 · Cited by 365
Lowe, J., McDermott, H., Landon, M., Mayer, R. J., & Wilkinson, K. D. (1990) · The Journal of Pathology · doi:10.1002/path.1711610210 · Cited by 356
Wakabayashi, K., Hayashi, S., Kakita, A., Yamada, M., Toyoshima, Y., Yoshimoto, M., & Takahashi, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050918 · Cited by 347
Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
Dehmer, T., Lindenau, J., Haid, S., Dichgans, J., & Schulz, J. B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742213.x · Cited by 337
Hasegawa, E., Takeshige, K., Oishi, T., Murai, Y., & Minakami, S. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90498-c · Cited by 319
Molecular and biochemical features of poly (ADP-ribose) metabolism
Lautier, D., Lagueux, J., Thibodeau, J., M�nard, L., & Poirier, G. G. (1993) · Molecular and Cellular Biochemistry · doi:10.1007/bf01076101 · Cited by 301
Trojanowski, J. Q., Goedert, M., Iwatsubo, T., & Lee, V. M.-Y. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400432 · Cited by 297
Hattori, N., Kitada, T., Matsumine, H., Asakawa, S., Yamamura, Y., Yoshino, H., Kobayashi, T., Yokochi, M., Wang, M., Yoritaka, A., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440612 · Cited by 296
MPTP Toxicity: Implications for Research in Parkinson's Disease
Kopin, I. J., & Markey, S. P. (1988) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.11.030188.000501 · Cited by 295
Dexter, D. T., Jenner, P., Schapira, A. H. V., Marsden, C. D., & The Royal Kings and Queens Parkinson's Disease Research Group (1992) · Annals of Neurology · doi:10.1002/ana.410320716 · Cited by 292
MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
Kowall, N. W., Hantraye, P., Brouillet, E., Beal, M. F., McKee, A. C., & Ferrante, R. J. (2000) · NeuroReport · doi:10.1097/00001756-200001170-00041 · Cited by 291
Shimura, H., Hattori, N., Kubo, S.-I., Yoshikawa, M., Kitada, T., Matsumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu, N., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<668::aid-ana19>3.0.co;2-z · Cited by 282
Synphilin-1 is present in Lewy bodies in Parkinson's disease
Wakabayashi, K., Engelender, S., Yoshimoto, M., Tsuji, S., Ross, C. A., & Takahashi, H. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4<521::aid-ana18>3.0.co;2-b · Cited by 266
El-Agnaf, O. M. A., Jakes, R., Curran, M. D., & Wallace, A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01419-7 · Cited by 258
Decreased ferritin levels in brain in Parkinson's disease
Dexter, D. T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A. J., Wells, F. R., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08814.x · Cited by 258
Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease
Hashimoto, M., & Masliah, E. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00552.x · Cited by 254
A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor
Farrer, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.81 · Cited by 248
Mitochondria in the etiology and pathogenesis of parkinson's disease
Schapira, A. H. V., Gu, M., Taanman, J. ‐., Tabrizi, S. J., Seaton, T., Cleeter, M., & Cooper, J. M. (1998) · Annals of Neurology · doi:10.1002/ana.410440714 · Cited by 238
Ishikawa, A., & Tsuji, S. (1996) · Neurology · doi:10.1212/wnl.47.1.160 · Cited by 233
Chapter 36: Astrocytes and Parkinson's disease
Forno, L. S., DeLanney, L. E., Irwin, I., Monte, D. D., & Langston, J. W. (1992) · Progress in Brain Research · doi:10.1016/s0079-6123(08)61770-7 · Cited by 230
The Role of Peroxynitrite in Nitric Oxide-Mediated Toxicity
Crow, J. P., & Beckman, J. S. (1995) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-79130-7_7 · Cited by 221
BECKMAN, J. S. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21791.x · Cited by 216
Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson’s disease
Maraganore, D. M., Farrer, M. J., Hardy, J. A., Lincoln, S. J., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.53.8.1858 · Cited by 209
LIPID PEROXIDATION AS CAUSE OF NIGRAL CELL DEATH IN PARKINSON'S DISEASE
Dexter, D., Carter, C., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92471-2 · Cited by 207
Forno, L. S., DeLanney, L. E., Irwin, I., & Langston, J. W. (1993) · PubMed · Cited by 207
Parkinson's disease in twins studied with 18 F‐dopa and positron emission tomography
Burn, D. J., Mark, M. H., Playford, E. D., Maraganore, D. M., Zimmerman, T. R., Duvoisin, R. C., Harding, A. E., Marsden, C. D., & Brooks, D. J. (1992) · Neurology · doi:10.1212/wnl.42.10.1894 · Cited by 197
Lücking, C., Abbas, N., Dürr, A., Bonifati, V, Bonnet, A.-M., de Broucker, T., De Michele, G., Wood, N., Agid, Y., & Brice, A. (1998) · The Lancet · doi:10.1016/s0140-6736(05)60746-5 · Cited by 188
Point Mutations (Thr240Arg and Ala311Stop) in theParkinGene
Hattori, N., Matsumine, H., Asakawa, S., Kitada, T., Yoshino, H., Elibol, B., Brookes, A. J., Yamamura, Y., Kobayashi, T., Wang, M., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9134 · Cited by 181
The etiology of Parkinson's disease with emphasis on the MPTP story
Langston, J. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.153s · Cited by 180
Role of mitochondria in the etiology and pathogenesis of Parkinson's disease
Mizuno, Y., Ikebe, S.-I., Hattori, N., Nakagawa-Hattori, Y., Mochizuki, H., Tanaka, M., & Ozawa, T. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00038-6 · Cited by 172
Seibyl, J. P., MAREK, K. L., Sheff, K., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., van Dyck, C. H., & Innis, R. B. (1998) · PubMed · Cited by 164
Gómez-Tortosa, E., Newell, K., Irizarry, M. C., Sanders, J. L., & Hyman, B. T. (2000) · Acta Neuropathologica · doi:10.1007/s004010051135 · Cited by 162
Leroy, E., Anastasopoulos, D., Konitsiotis, S., Lavedan, C., & Polymeropoulos, M. H. (1998) · Human Genetics · doi:10.1007/s004390050845 · Cited by 159
A novel transactivation domain in parkin
Morett, E., & Peer Bork, B. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01381-x · Cited by 151
Filaments of Lewy bodies contain insoluble cytoskeletal elements.
Galloway, P. G., Mulvihill, P., & Perry, G. L. (1992) · PubMed · Cited by 150
Manganese Superoxide Dismutase Overexpression Attenuates MPTP Toxicity
Klivenyi, P., St. Clair, D., Wermer, M., Yen, H.-C., Oberley, T., Yang, L., & Beal, M. F. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0191 · Cited by 142
Jensen, P. H., Islam, K., Kenney, J. M., Nielsen, M. S., Power, J., & Gai, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000099200 · Cited by 134
Mutated α-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance?
Papadimitriou, A., Veletza, V., Hadjigeorgiou, G. M., Patrikiou, A., Hirano, M., & Anastasopoulos, I. (1999) · Neurology · doi:10.1212/wnl.52.3.651 · Cited by 132
Piccini, P. P., Morrish, P., Turjanski, N., Sawle, G. V., Burn, D. J., Weeks, R. A., Mark, M. H., Maraganore, D. M., Lees, A. J., & Brooks, D. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410213 · Cited by 125
Vaughan, J. R. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.4.751 · Cited by 116
Holthoff‐Detto, V., Vieregge, P., Kessler, J., Pietrzyk, U., Herholz, K., Bonner, J. A., Wagner, R. L., Wienhard, K., Pawlik, G., & Heiss, W. (1994) · Annals of Neurology · doi:10.1002/ana.410360209 · Cited by 108
Oxidative stress in Parkinson's disease and other neurodegenerative disorders.
Jenner, P. G. (1996) · PubMed · Cited by 106
New Animal Models for Parkinson's Disease
Dawson, T. M. (2000) · Cell · doi:10.1016/s0092-8674(00)80629-7 · Cited by 94
Self-citationChan, P., Tanner, C. M., Jiang, X. M., & Langston, J. W. (1998) · Neurology · doi:10.1212/wnl.50.2.513 · Cited by 93
Maternal inheritance in Parkinson's disease
Wooten, G. F., Currie, L. J., Bennett, J. P., Harrison, M. B., Trugman, J. M., & Parker, W. D. (1997) · Annals of Neurology · doi:10.1002/ana.410410218 · Cited by 93
Bayer, T. A., Jäkälä, P., Hartmann, T., Havas, L., McLean, C., Culvenor, J. G., Li, Q.-X., Masters, C. L., Falkai, P., & Beyreuther, K. T. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00311-0 · Cited by 89
Cosi, C., Colpaert, F. C., Koek, W., Degryse, A.-D., & Marien, M. R. (1996) · Brain Research · doi:10.1016/0006-8993(96)00571-9 · Cited by 87
Pathobiology of the Lewy body.
Je, G., Vm, L., Schmidt, M. L., Ph, T., Iwatsubo, T., & Trojanowski, J. Q. (1999) · PubMed · Cited by 86
Matthews, R. T., Yang, L., & Beal, M. F. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6406 · Cited by 83
Forloni, G., Bertani, I., Calella, A. M., Thaler, F., & Invernizzi, R. W. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200005)47:5<632::aid-ana11>3.0.co;2-n · Cited by 82
Klivènyi, P., Andreassen, O. A., Ferrante, R. J., Schleicher, J. R., Friedlander, R. M., & Beal, M. F. (1999) · Neuroreport · doi:10.1097/00001756-199902250-00035 · Cited by 80
Semen examinations after vasectomy.
Jc, S. (1971) · PubMed · Cited by 79
Iron and ferritin in substantia nigra in Parkinson's disease.
Jellinger, K. A., Kienzl, E., Rumpelmaier, G., Paulus, W., Riederer, P., Stachelberger, H., Youdim, M. B. H., & Ben‐Shachar, D. (1993) · PubMed · Cited by 78
Mutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease
Parsian, A., Racette, B. A., Zhang, Z. H., Chakraverty, S., Rundle, M. M., Goate, A., & Perlmutter, J. S. (1998) · Neurology · doi:10.1212/wnl.51.6.1757 · Cited by 72
Harhangi, B. S., Farrer, M. J., Lincoln, S., Bonifati, V., Meco, G., Michele, G. D., Brice, A., Dürr, A., Martinez, M. M., Gasser, T., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00465-6 · Cited by 72
Sawle, G. V., Wroe, S. J., Lees, A. J., Brooks, D. J., & Frackowiak, R. S. J. (1992) · Annals of Neurology · doi:10.1002/ana.410320503 · Cited by 70
Schneider, J. S., & Denaro, F. (1988) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-198807000-00006 · Cited by 59
NOS knockouts and neuroprotection
Grünewald, T., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/70918 · Cited by 45
Itzhak, Y., Martin, J. L., & Ali, S. F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19991215)34:4<305::aid-syn6>3.0.co;2-# · Cited by 44
Genetics of Parkinson's disease
Mizuno, Y., Hattori, N., & Mori, H. (1999) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(99)80075-4 · Cited by 39
Jin, H., & Clayton, D. F. (1997) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1997.3795 · Cited by 36
Wang, W. W., Khajavi, M., Patel, B. J., Beach, J., Jankovic, J. J., & Ashizawa, T. (1998) · Archives of Neurology · doi:10.1001/archneur.55.12.1521 · Cited by 34
FREE RADICALS, LIPID PEROXIDATION, AND PARKINSON'S DISEASE
Smith, M., Sandy, M. S., & Monte, D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90722-7 · Cited by 25
A kindred with Parkinson’s disease not showing genetic linkage to established loci
Gwinn, K. A., Crook, R., Lincoln, S. J., Adler, C. H., Caviness, J. N., Hardy, J., & Farrer, M. J. (2000) · Neurology · doi:10.1212/wnl.54.2.504 · Cited by 23
Reply: a new look at the pathogenesis of Parkinson’s disease
Przedborski, S., Vila, M., Jackson-Lewis, V. R., & Dawson, T. M. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01470-x · Cited by 21
Self-citationLangston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Self-citationReactive oxygen species: from health to disease
Brieger, K., Schiavone, S., Miller Jr., F. J., & Krause, K.-H. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13659 · Cited by 1,133
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116
Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995
Metadata
- Authors
- Zhang, Y., Dawson, V. L., & Dawson, T. M.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 7
- Issue
- 4
- Pages
- 240-250
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2057323378
- Cited by
- 407
- References
- 122
- FWCI
- 18.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.